Navigation Links
Academies recommend new measures in antibiotic research
Date:1/28/2013

A growing number of infections worldwide are caused by bacteria resistant to antibiotics and ever fewer effective antibiotics are available. As a result, it is becoming increasingly difficult to treat infected patients successfully. In the statement, "Antibiotic Research: Problems and Perspectives", which was published today, the Academy of Sciences and Humanities in Hamburg and the German National Academy of Sciences Leopoldina list eight recommendations that show ways to prevent the further spread of antibiotic resistance and to develop urgently needed antibiotics.

"This development is a cause for grave concern. Our statement focuses on the contribution by research and on the necessary parameters in society," said Prof. Ansgar W. Lohse, spokesperson for the Working Group on Infection Research and Society at the Academy of Sciences and Humanities in Hamburg. "We need genuine incentives for new and more intensive antibiotic research so we can develop medications more quickly," he added.

"This field is a task for society as a whole," said Prof. Jrg Hacker, President of the German National Academy of Sciences Leopoldina. "Society does not only need greater research efforts and a faster translation of the findings into applications, but also dialogue on how antibiotics can be used responsibly and on how resistance can be prevented. We are setting up a round table on this topic and will invite all the relevant partners to join it."

According to the WHO, the global occurrence of antibiotic resistance poses one of the greatest threats to human health. It is estimated that around 25,000 patients die each year in the EU alone from an infection with bacteria that are resistant to antibiotics.


'/>"/>
Contact: Caroline Wichmann
presse@leopoldina.org
0049-034-547-239-800
Leopoldina
Source:Eurekalert

Page: 1

Related biology news :

1. Daniel Kahnemans Thinking, Fast and Slow wins best book award from academies
2. National Academies Keck Conference picks NYU-Poly citizen science researcher
3. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
4. Computing advances vital to sustainability efforts; new report recommends problem-focused, iterative approach to research
5. Effectiveness and impact of climate change mitigation measures unclear
6. Development of measures to prevent wine indispositions
7. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
8. Exposure to antibiotics linked to severity of allergic asthma: UBC research
9. Team discovers how bacteria resist a Trojan horse antibiotic
10. New antibiotic could make food safer and cows healthier
11. Hot on the trail of metabolic diseases and resistance to antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 23, 2017 Research and Markets has ... report to their offering. ... The Global Market for Bioproducts ... 2016 at a CAGR of 8.9%, This ... bioproducts into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
Breaking Biology Technology: